Analytical Data
-
基因名
AXL
-
简介
AXL protein is a receptor tyrosine kinase that mediates signals by binding to GAS6 and regulates cell survival, proliferation, migration and differentiation. After ligand binding, AXL dimerizes and autophosphorylates, activating downstream molecules, such as PI3 kinase subunits, GRB2, PLCG1, etc. AXL Protein, Human (HEK293, His-Avi) is the recombinant human-derived AXL protein, expressed by HEK293 , with C-Avi, C-His labeled tag.
- Application
-
别名
Axl; UFO; AXL oncogene; AXL; ARK; JTK11; Tyro7; AI323647; EC 2.7.10; EC 2.7.10.1
-
种属
Human
-
表达系统
HEK293
-
标签
C-Avi;C-8*His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P30530-1
-
表达区间
A26-P449
-
蛋白长度
Extracellular Domain
-
分子量
70-80 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
AXL is a receptor tyrosine kinase that plays a significant role in various cellular processes, including cell proliferation, survival, and migration. Originally discovered for its involvement in cancer progression and metastasis, AXL has garnered considerable attention in recent years due to its association with poor prognosis in multiple malignancies, particularly lung cancer and acute myeloid leukemia. The expression of AXL is often upregulated in response to external stimuli such as cytokines and growth factors, leading to the activation of downstream signaling pathways that promote tumorigenesis and therapy resistance. Researchers have been investigating AXL-targeted therapies, including monoclonal antibodies and small molecule inhibitors, as potential strategies to halt cancer progression and enhance the efficacy of existing treatments. The study of AXL recombinant proteins has become crucial for understanding its structure, function, and interaction with various ligands, particularly its ligand, Gas6. By producing and characterizing AXL recombinant proteins, scientists aim to elucidate the mechanisms of AXL signaling and its impact on cancer biology. The knowledge gained from these studies may pave the way for innovative therapeutic approaches targeting AXL, ultimately contributing to more effective cancer treatment strategies and improving patient outcomes.
